RxDoctor Payments Data

Joseph Kim, DPM

Podiatrist · Scranton, PANPI 1326626342

Payments from drug & device makers

$3,040in general payments, 2019–2025

Across 36 payments — averaging $84.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Smith+Nephew$263
  • Treace Medical Concepts, Inc.$256
  • Organogenesis Inc.$125
  • Novus Surgical Consultants$93
  • Novus Surgical Solutions LLC$89
  • plus $80 from 1 others

What the payments were for

  • Travel & lodging$1,05935%
  • Food & beverage$1,98165%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker25$2,135
Smith+Nephew4$263
Treace Medical Concepts, Inc.3$256
Organogenesis Inc.1$125
Novus Surgical Consultants1$93
Novus Surgical Solutions LLC1$89
Heron Therapeutics, Inc.1$80

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,040 in reported general payments places this provider in the 75th percentile of 445 podiatrist providers in Pennsylvania.

See all podiatrist providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$9,804
Medicare patients
102
Services billed
130

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate17$419

Paid to pharmacies, not to this prescriber.

Other podiatrist in Scranton

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →